Navigation Links
Orexigen® Therapeutics Presents Multiple Contrave® Data Presentations at the 29th Annual Scientific Meeting of The Obesity Society
Date:10/3/2011

d reinforces the robustness of the results."

An oral presentation by Gene-Jack Wang, MD, Chair of Brookhaven Laboratory's Medical Department, will outline neuroimaging data from a clinical study conducted in collaboration with Brookhaven National Laboratory.  Changes in brain response to food cues with Contrave or placebo treatment were assessed using functional MRI imaging and showed that Contrave enhanced the activation of brain regions involved in inhibitory control, internal awareness, memory and cognition following exposure to food cues.  These results further support the postulated mechanism by which Contrave may help patients control food cravings.

In addition, new analyses from the COR-I and COR-BMOD Phase 3 studies will be presented.  On average 34% and 17% of patients in COR-I receiving Contrave therapy for 1 year achieved weight loss milestones of >/=10 or >/=15%, respectively.  This level of weight loss translates to losing 60-73% of excess body weight, which is in the range reported for surgical procedures such as gastric banding.

About Contrave

Contrave, an investigational combination therapy of naltrexone HCl SR and bupropion HCl SR, was studied for its ability to help people with obesity initiate and sustain weight loss of at least 5 percent of their starting body weight in one year.  Contrave was submitted for U.S. regulatory approval in March 2010.  The original submission was based on multiple clinical trials that evaluated Contrave in more than 4500 patients.  Orexigen received a Complete Response letter from FDA on January 31, 2011.

About Orexigen Therapeutics

Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. Contrave has completed Phase 3 clinical trials, and the Company's other product candidate, Empatic(TM), has completed Phase 2 clinical trials. Further information about the Company can be f
'/>"/>

SOURCE Orexigen Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Orexigen® Therapeutics Announces FDA Acceptance of Contrave® New Drug Application for the Treatment of Obesity
2. Orexigen® Therapeutics Schedules August 5, 2010 Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2010
3. Orexigen® Therapeutics Announces Publication of COR-I Phase 3 Study of Contrave in Lancet
4. Orexigen® Therapeutics COR-BMOD Study Published in the Journal Obesity
5. Orexigen® Therapeutics and Takeda Enter Into Partnership to Commercialize Contrave® in North America
6. Orexigen® Therapeutics to Speak at Rodman & Renshaw Annual Global Investment Conference
7. Orexigen® Therapeutics to Speak at Fifth Annual JMP Securities Healthcare Conference
8. Orexigen® Therapeutics Reports Third Quarter 2010 Financial Results
9. Orexigen® Therapeutics Investigational Drug Contrave® Receives Positive Recommendation from FDA Advisory Committee for Treatment of Obesity
10. Orexigen® Therapeutics, Inc. Announces Upcoming Departure of Chief Financial Officer
11. Orexigen® Therapeutics Schedules March 10, 2011 Webcast Discussion of Financial Results for the Fourth Quarter and Year Ended December 31, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... -- Kinex Pharmaceuticals announced today that the first patient ... Institute. KX2-361 (KX02), a dual src/pre-tubulin inhibitor, ... inhibitory activity against a broad panel of brain tumor ... (T98G), the most widely used chemotherapy for the treatment ... model, KX2-361 consistently clears brain tumors after 4 weeks ...
(Date:12/24/2014)...  Diplomat Pharmacy, Inc. (NYSE: DPLO ), ... announce Jennifer Hagerman , Pharm.D., AE-C, senior director ... as the president of the Michigan Pharmacists Association on ... place Feb. 28, 2015, at the MPA Annual Convention ... Center in Detroit, Michigan . Hagerman ...
(Date:12/24/2014)... -- Echo Therapeutics, Inc. (NASDAQ: ECTE ... permeation, continuous glucose monitoring and associated technologies, today ... been appointed Chief Executive Officer effective December 22, ... of experience in the medical device, pharmaceutical and ... Vice President, Business Development, Otsuka Pharmaceuticals as well as ...
Breaking Medicine Technology:Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 2Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 3Diplomat's senior director of education and quality to be inducted as 2015 president of the Michigan Pharmacists Association 2Diplomat's senior director of education and quality to be inducted as 2015 president of the Michigan Pharmacists Association 3Echo Therapeutics Announces Scott W. Hollander as President & Chief Executive Officer 2Echo Therapeutics Announces Scott W. Hollander as President & Chief Executive Officer 3
... 2011 SCOLR Pharma, Inc. (OTCQB: SCLR) today announced that ... over-the counter (OTC) market beginning January 13, 2011 under the ... quoted on the OTC Bulletin Board and OTCQB™ Market on ... NYSE Amex Exchange at the close of business on January ...
... remote instrument support has expanded to include the Ventana ... is the leading innovator in the application of remote ... on the SYMPHONY H&E slide stainer. VMSI is now ... integration of the SYMPHONY and BenchMark platforms. For customers, ...
Cached Medicine Technology:SCOLR Pharma, Inc. Common Stock to Begin Trading on OTC Bulletin Board and OTCQB Stock Market on January 13, 2011 2CareGiver, Ventana Medical Systems, Inc. Remote Instrument Support, Has Expanded to Include the Ventana BenchMark ULTRA Automated Stainer 2CareGiver, Ventana Medical Systems, Inc. Remote Instrument Support, Has Expanded to Include the Ventana BenchMark ULTRA Automated Stainer 3
(Date:12/25/2014)... December 26, 2014 The ... combines beauty, strength and durability. Today, the business ... which is valid until Jan. 30, 2015. , ... of traditional hardwood. BambooFlooringChina.com is a well-known brand ... consumers worldwide to find a reliable bamboo flooring ...
(Date:12/25/2014)... 2014 Recently, iFitDress.com, the popular online supplier ... announced its new selection of black one-shoulder cocktail dresses ... now; they are available at discounted prices, up to 70% ... will last for three weeks only. You know, we have ... are interested in our new items can visit our website ...
(Date:12/25/2014)... December 25, 2014 Helen Harris’ RP ... Woodland Hills, California after an 8 year battle with ... Christmas Eve evening in her home in Woodland Hills ... breast cancer. , As the founder ... years, she pioneered and championed many of today's greatest ...
(Date:12/25/2014)... 2014 (HealthDay News) -- Overeating is common during the holidays, ... moderation, an expert says. "Don,t arrive at a party ... you know you,ll be attending a party, but deprivation leads ... dietitian at Northern Westchester Hospital in Mount Kisco, N.Y., said ... healthy during the day and even to have a snack ...
(Date:12/25/2014)... December 25, 2014 “ SmileStix ” was ... features the latest and coolest mobile applications on the iOS, ... and host of NewsWatch, conducted the app review and shared ... create personal stickers. , The old saying goes, “A picture ... of words that can describe a single image, because each ...
Breaking Medicine News(10 mins):Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2Health News:iFitDress.com: Black One-Shoulder Cocktail Dresses for 2015 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 4Health News:An Application to Create Custom Stickers was Featured on NewsWatch Television on December 19, 2014 2
... Although eight states boosted their sales taxes on cigarettes over ... of such increases by states compared to 2009, a new ... shows. One thing that smoking prevention experts know from ... go up, the CDC said. "Increasing cigarette excise ...
... significantly greater prevalence of early adverse life events , ... sexual abuse, according to a new study in ... the American Gastroenterological Association. "Various types of early ... bowel syndrome, particularly among women," said Lin Chang, MD, ...
... The American Society for Gastrointestinal Endoscopy (ASGE) has recognized ... dedicated to promoting quality in endoscopy, in all settings ... ASGE Endoscopy Unit Recognition Program honors endoscopy units that ... reprocessing and CDC infection control guidelines. To date, more ...
... Patients with end-stage liver disease complicated by the ... (HCC) are less likely to die or become ... new liver than those with other complications of end-stage ... School of Medicine at the University of Pennsylvania. The ...
... , WEDNESDAY, March 28 (HealthDay News) -- A drink ... death in the two decades following a heart attack, a new ... the European Heart Journal , included more than 1,800 American ... and were followed for up to 20 years. During that time, ...
... an isolated indigenous group in central Bolivia, Tsimane men spend ... by hand to grow crops. Their ability to maintain the ... have higher than average male testosterone levels. Anthropologists at ... however, that the baseline testosterone level of Tsimane men is ...
Cached Medicine News:Health News:States' Efforts to Boost Cigarette Taxes Slows: CDC 2Health News:Childhood traumatic experiences associated with adult IBS symptoms 2Health News:ASGE recognizes 18 endoscopy units for quality 2Health News:Penn researchers call for a re-examination of transplant waitlist prioritization 2Health News:Penn researchers call for a re-examination of transplant waitlist prioritization 3Health News:Moderate Drinking Might Help Men Live Longer After Heart Attack 2Health News:Low testosterone level in Amazonian tribe responds to competition 2
... Amvex offers a complete line of flowmeters, available ... are all available in a variety of calibrations to ... dials specific to the gas in use, the Amvex ... colors replace the U with I. For Power Take-Off ...
0-3.5 LPM Oxygen Flowmeter with Chemetronmale inlet...
0-15 LPM Oxygen Flowmeter with Chemetron male inlet...
(1/4-15 LPM). 50 psi back inlet, wall mounted, 1/8" NPT female....
Medicine Products: